Antiviral drugs

5-(9-ANTHRACENYL)PYRIDO[3 2-D]THIAZOLE

Reactant for preparation of: . HIV-1 integrase inhibitors targeting the catalytic domain and its ability for interaction with LEDGF/p75 . Inhibitors of Gli1-mediated transcription in the Hedgehog pathway . SCIO-469-like compounds for the inhibition

Reactant for preparation of: . HIV-1 integrase inhibitors targeting the catalytic domain and its ability for interaction with LEDGF/p75 . Inhibitors of Gli1-mediated transcription in the Hedgehog pathway . SCIO-469-like compounds for the inhibition

Reactant for preparation of: . HIV-1 integrase inhibitors targeting the catalytic domain and its ability for interaction with LEDGF/p75 . Inhibitors of Gli1-mediated transcription in the Hedgehog pathway . SCIO-469-like compounds for the inhibition

Reactant for preparation of: . HIV-1 integrase inhibitors targeting the catalytic domain and its ability for interaction with LEDGF/p75 . Inhibitors of Gli1-mediated transcription in the Hedgehog pathway . SCIO-469-like compounds for the inhibition

Purity Limit: &ge 99% (HPLC) CAS No.: 7659-06-5 Molecular Formula: C6H5N3O2 Molecular Weight: 151.12 MDL No.: MFCD01710630 Appearance: Off-white amorphous powder Melting Point: 220-227 ºC Storage Temperature: Store at 0-8 °C

Purity Limit: &ge 99% (HPLC) CAS No.: 7659-06-5 Molecular Formula: C6H5N3O2 Molecular Weight: 151.12 MDL No.: MFCD01710630 Appearance: Off-white amorphous powder Melting Point: 220-227 ºC Storage Temperature: Store at 0-8 °C

Application 5-Hydroxymethyl-2-furaldehyde (HMF) can be used in the synthesis of: Furan-2,5-dicarboxaldehyde (FDA) using a vanadyl phosphate-based catalyst via selective oxidation. Prepolymer and antiviral precursor,

Application 5-Hydroxymethyl-2-furaldehyde (HMF) can be used in the synthesis of: Furan-2,5-dicarboxaldehyde (FDA) using a vanadyl phosphate-based catalyst via selective oxidation. Prepolymer and antiviral precursor,

Application 5-Hydroxymethyl-2-furaldehyde (HMF) can be used in the synthesis of: Furan-2,5-dicarboxaldehyde (FDA) using a vanadyl phosphate-based catalyst via selective oxidation. Prepolymer and antiviral precursor,

5-(m-Tolyl)-5H-pyrrolo[3,2-c:4,5-c']dipyridine.

5-(pyridin-3-yl)-1,3-thiazol-2-amine.